|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/50 | |
| G01N 33/68 | |||
| G01N 33/53 | |||
| A61K 38/17 | |||
| C07D 473/34 | |||
| A61P 35/00 | |||
| G01N 33/574 |
| (11) | Number of the document | 2614369 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11824247.8 |
| Date of filing the European patent application | 2011-09-12 | |
| (97) | Date of publication of the European application | 2013-07-17 |
| (45) | Date of publication and mention of the grant of the patent | 2016-02-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/051258 |
| Date | 2011-09-12 |
| (87) | Number | WO 2012/034132 |
| Date | 2012-03-15 |
| (30) | Number | Date | Country code |
| 381684 P | 2010-09-10 | US |
| (72) |
COPELAND, Robert Allen, US
RICHON, Victoria Marie, US
SCOTT, Margaret Davis, US
SNEERINGER, Christopher John, US
KUNTZ, Kevin Wayne, US
KNUTSON, Sarah Kathleen, US
POLLOCK, Roy Macfarlane, US
|
| (73) |
Epizyme, Inc.,
400 Technology Square, 4th Floor, Cambridge, MA 02139,
US
|
| (54) | METHOD FOR DETERMINING THE SUITABILITY OF INHIBITORS OF HUMAN EZH2 IN TREATMENT |
| METHOD FOR DETERMINING THE SUITABILITY OF INHIBITORS OF HUMAN EZH2 IN TREATMENT |